Cost-Benefit Analysis of a Pharmacist’s Contribution in DecreasingAsthma-Related Economic and Health Burden with a Focus onthe Hispanic Population

Abstract

Asthma stands as one of the most prevalent and costly health conditions in the United States. Asthma affects over 27 million people in the U.S., which translates to approximately 1 in 12 individuals [1,2]. The burden of asthma in the United States is significantly higher among individuals with low income, senior adults, and Black, Hispanic, and American Indian/Alaska Native populations, who exhibit the highest rates of asthma-related fatalities, and hospitalizations [3].